The U.S. is putting too much fluoride into their water :
Biden administration scrambles to get additional 144,000 monkeypox vaccines as demand outstrips supply
The Biden administration is scrambling to get an additional 144,000 doses of monkeypox vaccines as demand outstrips supply in the United States.
“A sincere apology for the technical difficulties our vendor Medrite experienced with today’s monkeypox vaccine appointment rollout. We pledge to do better in the days and weeks ahead,” New York Health Commissioner Ashwin Vasan posted on Twitter on July 7.
Some 41,000 doses of the Jynneos vaccine have been distributed to states from the national stockpile by the national government and the Centers for Disease Control and Prevention.
“We are using every tool we have to increase and accelerate Jynneos vaccine availability in jurisdictions that need them the most,” Steve Adams, director of the Strategic National Stockpile, said in a news release.
He added that in less than 10 days, around 200,000 Jynneos vaccine doses would be available in communities where transmission has been the highest.
Monkeypox, a viral zoonotic disease, caused by the monkeypox virus, is recognized as the most significant orthopoxvirus infection after the eradication of smallpox. The current outbreak is mostly among gay, bisexual and other men who have sex with men, but anyone can get and spread monkeypox, the Health Department said.
As of July 11, 223 people in New York have tested positive for orthopoxvirus, and all cases are likely monkeypox. That is up from 111 cases on July 5 and more than quadruple the number from a week before that.
The government has ordered another 2.5 million doses of the vaccine for future monkeypox outbreaks and in case of smallpox outbreaks. These doses are expected to arrive in the stockpile in early 2023.
Biden slammed for concealing the real monkeypox vaccine situation
Meanwhile, the White House has faced criticisms for failing to secure the stockpile of Jynneos monkeypox vaccines in Denmark. Around one million doses are currently stuck at the Bavarian Nordic manufacturing facility allegedly due to red tape.
A June 28 letter sent to the Food and Drug Administration (FDA) commissioner and the Department of Health and Human Services (HHS) assistant secretary for Preparedness and Response pointed out that Americans have spent $2 billion since 2007 to “develop, manufacture, and stockpile” doses of the Jynneos vaccine as part of a federal security program.
The stockpile has over a million doses, enough to inoculate more than 500,000 people from at-risk areas.
“But members of the at-risk communities in the U.S. are being turned away from monkeypox vaccination because these vaccines are not available in sufficient quantity in the U.S., but are instead sitting in freezers in Denmark,” the letter stated.
@NaturalNewsMedia
?????? Read more ??????